Cleared Traditional

K820341 - CORTISOL-SQUIBB RADIOIMMUNOASSAY KIT

K820341 is the FDA 510(k) clearance for CORTISOL-SQUIBB RADIOIMMUNOASSAY KIT by E. R. Squibb & Sons, Inc.. It is a Class 2 Toxicology device (product code CGR) cleared through the Traditional 510(k) pathway after a 24-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1982
Decision
24d
Days
Class 2
Risk

K820341 is an FDA 510(k) clearance for the CORTISOL-SQUIBB RADIOIMMUNOASSAY KIT. Classified as Radioimmunoassay, Cortisol (product code CGR), Class II - Special Controls.

Submitted by E. R. Squibb & Sons, Inc. (New York, US). The FDA issued a Cleared decision on March 4, 1982 after a review of 24 days - a notably fast clearance cycle.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.1205 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all E. R. Squibb & Sons, Inc. devices

Submission Details

510(k) Number K820341 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 08, 1982
Decision Date March 04, 1982
Days to Decision 24 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
63d faster than avg
Panel avg: 87d · This submission: 24d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CGR Radioimmunoassay, Cortisol
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1205
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.

Regulatory Peers - CGR Radioimmunoassay, Cortisol

All 47
Devices cleared under the same product code (CGR) and FDA review panel - the closest regulatory comparables to K820341.
EMIT SRD MANUAL CORTISOL ASSAY
K831141 · Syva Co. · May 1983
SOPHEIA CORTISOL EIA KIT
K822845 · Diagnostic Products Corp. · Oct 1982
DSL 1020
K821068 · Diagnostic Systems Laboratories, Inc. · May 1982
COAT-A-COUNT CORTISOL RIA KIT
K810891 · Diagnostic Products Corp. · Apr 1981
ENDAB CORTISOL KIT
K810192 · Immunotech Corp. · Feb 1981
ARIA II 125 I CORTISOL
K802380 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Oct 1980